US Stock MarketDetailed Quotes

ACHL Achilles Therapeutics

Watchlist
  • 1.480
  • 0.0000.00%
Close Mar 20 16:00 ET
60.83MMarket Cap-0.89P/E (TTM)

About Achilles Therapeutics Company

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Company Profile

SymbolACHL
Company NameAchilles Therapeutics
Issue Price18.00
CEODr. Iraj Ali, PhD
MarketNASDAQ
Employees215
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Iraj Ali, PhD
  • Chief Executive Officer and Director
  • 1.70M
  • Robert Coutts
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Sergio Quezada, PhD
  • Chief Scientific Officer
  • --
  • Dr. Karl Peggs, M.D.
  • Chief Medical Officer
  • --
  • Dr. Edwin Moses, B.Sc. ,PhD
  • Chairman of the Board
  • 379.00K
  • Julie ONeill
  • Independent Director
  • 102.00K
  • Carsten Boess
  • Independent Director
  • 176.00K
  • Dr. Michael F. Giordano, M.D.
  • Independent Director
  • 189.00K
  • Dr. Bernhard R.M. Ehmer
  • Independent Director
  • 106.00K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More